Nasal spray oxytocin for benzodiazepine withdrawal
Treatments studied
Part of Mental health clinical trials.
This trial tests if a nasal spray containing the hormone oxytocin can help reduce withdrawal symptoms when stopping benzodiazepine (benzos) medications like Valium. You might be eligible if you have been taking a moderate to high daily dose of a benzodiazepine and are entering a hospital program to taper off.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You take a benzodiazepine medicine (such as Valium or Xanax) every day, at a dose that equals 20 to 80 mg of diazepam.
- You need to be in the hospital to safely stop or reduce this medication.
- You are willing to complete a study and answer questionnaires.
- You are not pregnant, planning pregnancy, or breastfeeding.
- You do not have a serious medical or psychiatric condition that needs emergency care.
- You do not have an alcohol, pregabalin, or gabapentin use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether baclofen can make it easier to reduce (taper) benzodiazepines in people who have been dependent for a long time and previously had trouble stopping. If you can safely take part, it may help improve the tapering process and reduce withdrawal problems.
This early-phase study tests whether a spray of oxytocin in the nose can be given safely and may affect symptoms in people with arginine-vasopressin deficiency. You might qualify if your hormone levels are stable and you can safely take the nasal study medicine during the study period.
This study tests whether a brief motivational interview can help people safely reduce or stop taking benzodiazepines or Z-drugs (like sleeping pills or anxiety meds) they have used daily for at least 6 months. It aims to support patients in trying to lower their dose with their doctor's guidance.
This early trial studies whether Syntocinon can lower pain and help reduce how much opioids people use. It checks safety and the best dose by giving participants the study drug under close medical monitoring.
This trial tests a nasal spray called midazolam to quickly reduce anxiety in people receiving palliative care. If you're an adult in the hospital with sudden anxiety, this could help you feel calmer.
This study tests whether an oxytocin nasal spray affects social behavior and hormones in postmenopausal women. Being postmenopausal may change how the body responds to oxytocin, so this research aims to see if it can help with mood or social connections.
Hear when a new Benzodiazepine Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.